Cargando…

Hydroxyurea: A useful adjunct to the standard antiviral therapy in chronic hepatitis B

Detalles Bibliográficos
Autor principal:	Alavi-Moghaddam, Mostafa
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Kowsar 2011
Materias:	Letter to Editor
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3206681/ https://www.ncbi.nlm.nih.gov/pubmed/22087148

Ejemplares similares

Melanonychia and skin hyperpigmentation with hydroxyurea therapy
por: Koley, Sankha, et al.
Publicado: (2010)

Antiviral therapy leads to histological improvement in HBeAg-negative chronic hepatitis B patients
por: Basyigit, Sebahat, et al.
Publicado: (2015)

Hydroxyurea-induced Tooth Discoloration
por: Okuyucu, Muhammed, et al.
Publicado: (2020)

The use of hydroxyurea pretreatment in chronic myeloid leukemia in the current tyrosine kinase inhibitor era
por: Kockerols, Camille C.B., et al.
Publicado: (2022)

Antiviral therapy in acute viral hepatitis B: why and when
por: Morelli, Giuseppe, et al.
Publicado: (2009)

Monkeypox Outbreak in Non-Endemic Areas: Will it Cause a New Pandemic? a Letter to Editor
por: Alavi-Moghaddam, Mostafa
Publicado: (2022)

Menopause in Brazilian women with sickle cell anemia with and without hydroxyurea therapy
por: Queiroz, Ana Mach, et al.
Publicado: (2021)

A Novel Coronavirus Outbreak from Wuhan City in China, Rapid Need for Emergency Departments Preparedness and Response; a Letter to Editor
por: Alavi-Moghaddam, Mostafa
Publicado: (2020)

Initiating adjunct low-dose hydroxyurea therapy for stroke prevention in children with SCA during the COVID-19 pandemic
por: DeBaun, Michael R.
Publicado: (2020)

Amazing Results with Hydroxyurea Therapy in Chronic Hepatitis B: A Preliminary Report
por: Kashani, Hessam Hassanzadeh, et al.
Publicado: (2010)

Willing to Pay for Antiviral Treatment of Hepatitis B Patients
por: ZHANG, Hua, et al.
Publicado: (2016)

Blood lactic acid increased by hydroxyurea in a leukemia patient
por: Hu, Jing, et al.
Publicado: (2019)

Pharmacological adjuncts for chronic venous ulcer healing
por: Coccheri, Sergio, et al.
Publicado: (2015)

Feasibility of adjunct tele-yoga therapy in patients with substance use disorders
por: Bhargav, Hemant, et al.
Publicado: (2022)

Critics on "Adjunctive Memantine Therapy for Cognitive Impairment in Chronic Schizophrenia: A Placebo-Controlled Pilot Study"
por: Pae, Chi-Un
Publicado: (2013)

Efficacy of Entecavir therapy in elderly patients with chronic hepatitis B infection
por: Tan, You-wen, et al.
Publicado: (2014)

Cardiotoxicity of current antipsychotics: Newer antipsychotics or adjunct therapy?
por: Liu, Zheng, et al.
Publicado: (2022)

Pegylated interferon/telbivudine sequential therapy in Hepatitis Be antigen negative severe chronic hepatitis B patient
por: Caroleo, Benedetto, et al.
Publicado: (2013)

Risk of hepatitis B virus reactivation in chronic lymphocytic leukemia patients receiving ibrutinib with or without antiviral prophylaxis. A retrospective multicentric GIMEMA study
por: Innocenti, Idanna, et al.
Publicado: (2022)

A Useful Adjunct in Lower Limb Surgery
por: Ahmad, Zeeshan, et al.
Publicado: (2014)

Mirror therapy: An adjunct to conventional pharmacotherapy in phantom limb pain
por: Datta, Rashmi, et al.
Publicado: (2015)

Current Antiviral Therapy for Chronic Hepatitis B
por: Lim, Young-Suk, et al.
Publicado: (2004)

Antiviral therapy for chronic hepatitis B in China
por: Zheng, Xin, et al.
Publicado: (2014)

Current Antiviral Therapy of Chronic Hepatitis B: Efficacy and Safety
por: Lam, Yuk-Fai, et al.
Publicado: (2011)

A challenge in distinguishing between acute hepatitis B and acute exacerbation of chronic hepatitis B
por: Baek, Yang-Hyun
Publicado: (2020)

Seroconversion of Hepatitis B Virus Surface Antigen in Chronic Hepatitis B Child Treated with Entecavir
por: Li, Dong, et al.
Publicado: (2012)

Dapagliflozin as an adjunct therapy to insulin in the treatment of patients with type 1 diabetes mellitus
por: Tamez, Hector E., et al.
Publicado: (2015)

Adjunctive treatment for leg ulcers
por: Langer, Vijay
Publicado: (2014)

Does currently recommended maternal antiviral prophylaxis against mother-to-child transmission of hepatitis B virus require enhancement?
por: Zhou, Yi-Hua, et al.
Publicado: (2023)

Discontinuation of antiviral therapy in chronic hepatitis B patients
por: Medas, Renato, et al.
Publicado: (2021)

Current Trend in Antiviral Therapy for Chronic Hepatitis B
por: Chien, Rong-Nan, et al.
Publicado: (2022)

Yoga as an adjunct modality for promotion of healthy use of information technology
por: Sharma, Manoj Kumar, et al.
Publicado: (2016)

Repurposing Hepatitis C Direct-Acting Antivirals Against COVID-19
por: Kumar, Pramod, et al.
Publicado: (2021)

Reply from authors: Adjunctive endovascular options for chronic type B aortic dissection
por: Yost, Gardner, et al.
Publicado: (2022)

Functional Immune Reconstitution by Interleukin-2 Adjunctive Therapy for HIV/Mycobacterial Co-infection
por: Heyckendorf, Jan, et al.
Publicado: (2015)

Chronic hepatitis B patients: A relation of age and comorbidities
por: Vyas, Ashish K., et al.
Publicado: (2019)

Two Cases of Myeloproliferative Neoplasm with a Concurrent JAK2(V617F) Mutation and BCR/ABL Translocation without Chronic Myelogenous Leukemia Phenotype Acquisition during Hydroxyurea Treatment
por: Park, Sang Hyuk, et al.
Publicado: (2013)

Reply to: “Does currently recommended maternal antiviral prophylaxis against mother-to-child transmission of hepatitis B virus require enhancement?”
por: Matthews, Philippa C., et al.
Publicado: (2023)

Risk of Reactivation of Hepatitis B in Hepatitis B Surface Antigen-Negative and Hepatitis B Core Antigen Antibody Positive Patients Receiving Biologic Therapy
por: Gök Sargın, Zeynep
Publicado: (2023)

Vitamins as adjunctive treatment for coronavirus disease!
por: Kapoor, Indu, et al.
Publicado: (2020)

Cannot write session to /tmp/vufind_sessions/sess_q5po97ijvnpa81mel95nj9tf7j